Author Affiliation: Division of Urology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
The timely report on preventive treatments for recurrent urinary tract infections (UTIs), Beerepoot et al1(p711) concluded that oral lactobacilli, when compared with trimethoprim-sulfamethoxazole, “did not meet the noninferiority criteria.”1(p711) Although this phraseology is technically correct, its meaning is somewhat opaque, and others have misunderstood the study to demonstrate that lactobacilli “were inferior to”2 or “not as effective as”3 antibiotic prophylaxis. Greater clarity may have been achieved by following the example of the Consolidated Standards of Reporting Trials (CONSORT) Group and declaring the data “inconclusive,” since the 95% confidence interval for between-treatment difference in number of symptomatic UTIs overlapped the noninferiority margin.4
Faasse MA. Lactobacilli vs Antibiotics to Prevent Recurrent Urinary Tract Infections: An Inconclusive, Not Inferior, Outcome. Arch Intern Med. 2012;172(21):1690–1694. doi:10.1001/archinternmed.2012.4427
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: